Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Eating and Weight Disorders : EWD
|
March 23, 2000
D4 dopamine receptor gene exon III polymorphism and obesity risk
W S Poston, M Ericsson, J Linder, et al.
Endocrinology
|
April 9, 2014
Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats
M P Mosti, A K Stunes, M Ericsson, et al.
The Journal of Biological Chemistry
|
January 25, 1991
Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone
F E Cohen, G J Strewler, M S Bradley, et al.
The Journal of Cell Biology
|
December 1, 1994
Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells
G Griffiths, M Ericsson, J Krijnse-Locker, et al.
Nature
|
September 25, 1980
VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion
B Ahrén, J Alumets, M Ericsson, et al.
The Journal of Cell Biology
|
May 1, 1993
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks
B Sodeik, R W Doms, M Ericsson, et al.
The Journal of Clinical Investigation
|
December 15, 1996
Identification and localization of polycystin, the PKD1 gene product
L Geng, Y Segal, B Peissel, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2004
A 13C NMR approach to categorizing potential limitations of alpha,beta-unsaturated carbonyl systems in drug-like molecules
Kevin P Cusack, Lee D Arnold, Claude E Barberis, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2006
Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
Jürgen Dinges, Irini Akritopoulou-Zanze, Lee D Arnold, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization
Christopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Eating and Weight Disorders : EWD
|
March 23, 2000
D4 dopamine receptor gene exon III polymorphism and obesity risk
W S Poston, M Ericsson, J Linder, et al.
Endocrinology
|
April 9, 2014
Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats
M P Mosti, A K Stunes, M Ericsson, et al.
The Journal of Biological Chemistry
|
January 25, 1991
Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone
F E Cohen, G J Strewler, M S Bradley, et al.
The Journal of Cell Biology
|
December 1, 1994
Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells
G Griffiths, M Ericsson, J Krijnse-Locker, et al.
Nature
|
September 25, 1980
VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion
B Ahrén, J Alumets, M Ericsson, et al.
The Journal of Cell Biology
|
May 1, 1993
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks
B Sodeik, R W Doms, M Ericsson, et al.
The Journal of Clinical Investigation
|
December 15, 1996
Identification and localization of polycystin, the PKD1 gene product
L Geng, Y Segal, B Peissel, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2004
A 13C NMR approach to categorizing potential limitations of alpha,beta-unsaturated carbonyl systems in drug-like molecules
Kevin P Cusack, Lee D Arnold, Claude E Barberis, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2006
Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
Jürgen Dinges, Irini Akritopoulou-Zanze, Lee D Arnold, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization
Christopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Page
of 12